Birmingham Biotech partners with University of Birmingham to commercialize novel anti-viral nasal spray

By | November 10, 2021
Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.